Foxx Life Sciences Marks Milestone with Successful Open House in Hyderabad, India

Foxx Life Sciences recently celebrated a significant achievement with the successful hosting of its Open House event at the company's Hyderabad facility in India. The event on February 17, 2025, attracted a diverse group of industry leaders, partners, and community members, underscoring Foxx Life Sciences’ ongoing commitment to driving innovation and excellence within the life sciences sector. During the Open House, Foxx Life Sciences proudly marked its fifth anniversary of bioprocess manufacturing in India and unveiled two new manufacturing plants, including a state-of-the-art blow and injection molding facility that spans an impressive 40,000 square feet. Guests were given the exclusive opportunity to engage with the company's experts, explore the latest advancements in manufacturing, and learn about Foxx Life Sciences’ innovative solutions. Thomas Taylor, the Founder and CEO of Foxx Life Sciences, expressed his enthusiasm about the event’s turnout and the positive feedback received from attendees. He emphasized, “This event underscores our dedication to fostering innovation and collaboration in India within the life sciences community.” Eknath Kulkarni, Co-Founder and President of Foxx Life Sciences APAC, also conveyed excitement about the event, stating, “We are excited to continue building strong relationships with our customers, suppliers, and employees with these significant investments. From R&D, prototyping, machining, welding, injection molding, clean room assembly, to Asia logistics, Foxx is ready to support our global customers.” Rick Schwartz, President of Foxx Life Sciences, added to the sentiment by highlighting the Open House as a valuable opportunity to display the company's capabilities and share its vision. He stated, “We are committed to driving growth and excellence in the industry, and events like this help us connect with the community and highlight our contributions.” The opening of the two new plants in Hyderabad further enhances Foxx Life Sciences’ global positioning and strengthens its manufacturing redundancies, which are vital for clients in the vaccine, biotech, pharma, and medical sectors. With a commitment to quality emphasized through its ISO 13485 certification since 2010, along with seven certified ISO Class 7 clean rooms and five manufacturing plants, Foxx Life Sciences is poised to be an ideal partner for your next life science disposable product or bioprocess single-use custom assembly. Foxx Life Sciences, located just 42 miles from Boston, is a leader in custom single-use technology (SUT), offering a range of products including tubing, bags, bottles, filters, and laboratory safety equipment for the research, biotech, diagnostic, medical, and pharmaceutical industries. For further details, contact Foxx Life Sciences at 1-603-890-FOXX (3699) or visit their website at www.foxxlifesciences.com.

Topics General Business)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.